Candela Aesthetic Device Footprint: FDA 510(k) Clearances, Recalls, and MAUDE Context

What does the public regulatory data reveal about Candela and its aesthetic device portfolio, and what should a buyer, medical director, clinical operator, or regulatory affairs team do with it?

Analysis of the FDA medical device databases reveals that Candela holds one of the largest regulatory footprints in energy-based aesthetic systems. This dossier aggregates and analyzes 113 FDA 510(k) clearances—including 102 clearances under the surgical laser product code GEX and 4 under the light-based wrinkle reducer code ONF—alongside its historical recalls and 385 adverse event reports in the FDA's Manufacturer and User Facility Device Experience (MAUDE) database.

For clinical buyers and practice managers, this data highlights Candela's dominant market footprint, maps the technical risk boundaries of its leading platforms (GentleMax Pro, Vbeam, PicoWay, and Profound), and parses historical recalls to provide an objective risk-management framework.

---

1. Corporate History, Strategic Acquisitions, and the Rebranding of an Industry Pioneer

Founded in 1970 in Wayland, Massachusetts, Candela Corporation is one of the oldest and most established developers of aesthetic laser technologies in the world. The company's corporate trajectory is a case study in industry consolidation, strategic mergers, and rebranding campaigns:

• Pioneering Era (1970–1990s): Candela entered the scientific and medical markets by developing advanced laser systems. In the late 1980s, the company introduced the first clinically successful Pulsed Dye Laser (PDL) for vascular lesions (port-wine stains) in pediatric patients, establishing a clinical baseline for selective photothermolysis.
• The Syneron Era and the 2009 Merger: Syneron Medical Ltd. was founded in Israel in 2000 by Dr. Shimon Eckhouse and IP developer Michael Kreindel. Syneron grew rapidly due to its proprietary elōs (Electro-Optical Synergy) technology, which combined radiofrequency (RF) energy with optical energy (laser or IPL) to treat skin indications. In 2009, Syneron acquired Candela Corporation for approximately $65 million, forming a combined entity known commercially as "Syneron Candela."
• Private Equity Acquisition (2017): In July 2017, global investment firm Apax Partners acquired Syneron Candela for approximately $397 million, taking the company private to focus on operational scaling and new product development.
• The March 2019 Rebranding: On March 1, 2019, the company announced a global rebranding, retiring the "Syneron Candela" name and consolidating all global operations under the single name Candela.
• Continued Corporate Expansion (2020–2026): Under private equity ownership, Candela has modernized its flagship consoles, releasing the GentleMax Pro Plus and Vbeam Prima systems while expanding clinical indications for its picosecond and RF platforms.

These corporate milestones consolidated a diverse regulatory landscape, bringing multiple 510(k) clearances and product lines under Candela's compliance framework.

---

2. Candela's 510(k) Clearance Map

Unlike pharmaceuticals or Class III medical devices (such as breast implants) that undergo a Premarket Approval (PMA) pathway, the vast majority of energy-based aesthetic devices are cleared via the FDA's 510(k) premarket notification process. A 510(k) clearance requires the manufacturer to demonstrate that a new device is "substantially equivalent" in safety and efficacy to a legally marketed predicate device.

Analysis of Product Codes

A search of the FDA Medical Device 510(k) Database shows that Candela/Syneron holds 113 clearances in our database slice across four primary product codes:

1. GEX (Laser instrument, surgical): With 102 clearances, this represents the foundation of Candela’s product portfolio. It covers the entire GentleLase, GentleYAG, GentleMax, Vbeam, AlexTriVantage, and PicoWay laser lines.
2. OHV (Light Based Over-The-Counter Wrinkle Reduction): With 6 clearances, representing Candela's historical exploration of consumer/home-use light-based skin treatments.
3. ONF (Light-Based Wrinkle Reducer): With 4 clearances, covering professional light-based systems marketed specifically for wrinkle reduction and non-invasive skin remodeling.
4. OLP (Laser Surgical Instrument, Gynecologic): With 1 clearance, covering specialized laser configurations for gynecological applications.

Selected Candela FDA 510(k) Clearances

To illustrate Candela's regulatory timeline, the following table lists 15 representative clearances spanning their primary technology pillars:

---

3. Core Platforms: Technical Mechanics and Laser Physics

Candela’s clinical reputation and market share are defined by four distinct energy-based platforms, each utilizing a specific technological mechanism:

GentleMax Pro & GentleMax Pro Plus: Dual-Wavelength Workstations

The GentleMax Pro family represents the industry standard for laser hair removal and superficial vascular treatments. The workstation integrates two distinct lasers:

• 755nm Alexandrite Laser: High absorption in melanin, making it highly effective for hair removal in Fitzpatrick skin types I–IV and epidermal pigmented lesions.
• 1064nm Nd:YAG Laser: Lower melanin absorption but deeper penetration, bypassing the epidermis to target the deep hair follicle. This makes it the safest option for hair removal in dark skin types (Fitzpatrick V–VI) and pseudofolliculitis barbae.
• Spot Size Versatility: The GentleMax Pro Plus supports spot sizes ranging from 1.5mm (for targeted facial telangiectasias) up to 24mm (for rapid hair removal on large body areas). Larger spot sizes deliver deeper light penetration due to reduced scattering at the tissue margins.
• Dynamic Cooling Device (DCD) Physics: Candela's proprietary cooling method. The system sprays a cryogen coolant (HFC-134a) onto the skin in millisecond bursts immediately before and after the laser pulse. This keeps the epidermis at a safe, comfortable temperature, reducing the risk of epidermal burns while allowing the use of higher fluences. The timing parameters are highly customizable:
  • DCD Spray Duration: 20 ms to 50 ms.
  • DCD Delay: 20 ms to 50 ms (allows the cryogen to evaporate, cooling the stratum corneum before the laser energy strikes).
  • DCD Post-Spray: 10 ms to 30 ms (optional, providing post-pulse thermal relief to the epidermis).

Vbeam (Perfecta and Prima): 595nm Pulsed Dye Lasers (PDL)

The Vbeam platform is the clinical gold standard for vascular treatments, targeting blood vessels in rosacea, telangiectasias, port-wine stains, hemangiomas, and bruising. For how the 595nm Vbeam compares with the Cutera Excel V KTP platform for vascular redness, see our Vbeam vs Excel V comparison.

• Wavelength Selection (595nm): The 595nm wavelength matches one of the absorption peaks of oxyhemoglobin. The energy is absorbed by blood vessels, causing rapid heating and coagulation (photothermolysis) while sparing the surrounding tissue.
• The Dye Module and Liquid Medium: PDL systems use a liquid dye medium (typically Rhodamine 590 dissolved in a solvent) to generate light. This dye is pumped through a dye kit module. Over time, the intense flashlamp exposure degrades the dye, requiring replacement of the dye kit after a set number of pulses (typically 20,000 to 50,000 shots depending on the fluence settings).
• Vbeam Prima Evolution: The Prima platform adds a secondary 1064nm Nd:YAG wavelength to target deeper blue/purple vascular structures (such as venous lakes and leg veins) and incorporates an integrated handpiece that supports both DCD cryogen cooling and contact cooling.

PicoWay: Multi-Wavelength Picosecond Laser

Cleared under K140880, PicoWay was developed to challenge Q-switched nanosecond lasers for tattoo removal and skin revitalization. For a head-to-head comparison of Candela's PicoWay against Cynosure's PicoSure across tattoo and pigment work, see our PicoSure vs PicoWay comparison.

• Picosecond Pulses: PicoWay delivers energy in picoseconds (one-trillionth of a second). This ultra-short duration is shorter than the thermal relaxation time of tattoo pigment.
• Ultra-High Peak Power: PicoWay generates peak powers of up to 0.9 Gigawatts. This massive energy spike delivers a photoacoustic shockwave, fracturing pigment particles into microscopic dust that the body's lymphatic system can easily clear, without generating heat that could burn the skin.
• Modular Handpieces: PicoWay supports wavelengths of 532nm (red/orange inks), 1064nm (dark inks/dark skin), 730nm (green/blue inks), and 785nm (blue/green inks). It also features a Resolve holographic fractional handpiece for treating acne scars and wrinkles.

Profound: Radiofrequency Microneedling

Originally cleared under the name "ePrime" (K101185), Profound is an RF microneedling platform that targets skin laxity and cellulite. For how Profound's temperature-controlled RF needling compares against Morpheus8 and Sylfirm X, see our Morpheus8, Sylfirm, and Profound comparison.

• Temperature-Controlled RF: Profound uses bipolar RF needles that penetrate the dermis and deliver energy to heat the tissue. It is the only RF microneedling device with real-time temperature sensors in the needles, maintaining the target dermal temperature at exactly 67°C for 3 to 4 seconds.
• Needle Configuration Angles:
  • Dermal Cartridge: Consists of 5 pairs of micro-needle electrodes (10 needles total) that penetrate the skin at a 45-degree angle to a fixed depth of 1.5mm, targeting the reticular dermis.
  • Subq Cartridge: Consists of 7 pairs of micro-needle electrodes (14 needles total) that penetrate the skin at a 45-degree angle to a deeper target of 6.0mm, targeting subcutaneous fat pads.

---

4. Clinical Protocols and Laser Parameters

Clinical success with Candela devices relies on adjusting parameters—wavelength, pulse duration, fluence, spot size, and cooling variables—to the patient's skin type and indication.

The following clinical settings matrix provides representative parameters for various dermatological indications across Candela platforms:

GentleMax Pro (Hair Removal Protocol Notes)

• Wavelength: 755nm for Fitzpatrick I–IV; 1064nm for Fitzpatrick V–VI.
• Pulse Width: Typically adjusted from 3 ms (for fine hair) up to 20 ms or 100 ms (for coarse hair or darker skin).
• Fluence: 12–20 J/cm² on the Alexandrite; 14–22 J/cm² on the Nd:YAG.
• DCD Settings: Standard starting parameters require a 30 ms spray duration and a 20 ms delay before the laser pulse. Clinicians must calibrate the DCD regularly; insufficient cryogen spray increases burn risk, while excessive spray can cause cryogen burns or localized hypopigmentation.

Vbeam Perfecta (Vascular Rosacea Protocol Notes)

• Spot Size & Fluence: 10mm spot size at 7.0–8.5 J/cm², or a 12mm spot size at 5.0–6.5 J/cm². Larger spot sizes provide deeper penetration.
• Pulse Duration: Long pulse widths (e.g., 6 ms to 10 ms) are used to heat the vessel slowly, causing coagulation without rupturing the vessel wall (which avoids purpura/bruising). Short pulse widths (e.g., 0.45 ms or 1.5 ms) intentionally rupture vessels, causing immediate purpura, which is more effective for resistant vascular lesions but requires 7–14 days of social downtime.
• DCD Cooling: Typically set to a 30 ms spray and a 20 ms delay to protect the epidermis from the intense heat generated in the blood vessels.

PicoWay (Tattoo Removal Protocol Notes)

• Wavelength Selection: 1064nm is the primary choice for black and dark blue inks, and is safe for all skin types. 532nm is used for red and orange inks, restricted to skin types I–III due to high epidermal melanin absorption.
• Fluence Range: Starting at 1.5–2.2 J/cm² for a 4mm spot size, gradually increasing the fluence as the tattoo fades and the target pigment density decreases.
• Clinical Endpoint: The target endpoint is immediate "frosting"—a white, transient epidermal gas bubble caused by the photoacoustic reaction. If blistering or bleeding occurs immediately, the fluence must be reduced.

---

5. Laser Physics: Photothermal vs. Photomechanical

The clinical distinction between legacy lasers and picosecond technology lies in the physics of energy delivery.

  THERMAL VS. MECHANICAL LASER ENERGY DELIVERY
  ┌─────────────────────────────────────────────────────────┐
  │ 1. Legacy Nanosecond Lasers (Q-Switched):               │
  │    * Pulse duration: 10^-9 seconds                      │
  │    * Interaction: Photothermal heating                  │
  │    * Action: Heats pigment to shatter it                │
  │    * Risk: Thermal diffusion causes surrounding damage  │
  │                                                         │
  │ 2. Candela Picosecond Lasers (PicoWay):                 │
  │    * Pulse duration: 10^-12 seconds                     │
  │    * Interaction: Photomechanical pressure              │
  │    * Action: Acoustic shockwave shatters pigment        │
  │    * Benefit: Minimal heat transfer, safer for dark skin│
  └─────────────────────────────────────────────────────────┘

Acoustic and Thermal Relaxation Times

• Thermal Relaxation Time (TRT): The time required for a target structure (like a melanosome or hair follicle) to lose 50% of its heat to surrounding tissue. To prevent thermal damage to the skin, a laser pulse must be shorter than the target's TRT.
• Acoustic Relaxation Time (ART): The time required for an acoustic pressure wave to travel across the target particle. To achieve photomechanical shattering without heating the surrounding skin (known as stress confinement), the laser pulse must be shorter than the target's ART.
• Stress Confinement: PicoWay’s sub-nanosecond pulse width (ranging from 300 to 450 picoseconds) is shorter than the ART of tiny tattoo ink and melanin particles. This allows pressure to build up inside the target particle faster than it can expand, causing it to fracture photomechanically into microscopic dust that is cleared by macrophages.
• Laser-Induced Optical Breakdown (LIOB): When using the PicoWay Resolve fractional handpiece, the high peak power of the picosecond pulse strips electrons from atoms at the focal point, creating microscopic plasma cavities in the epidermis without breaking the stratum corneum. These LIOB vacuoles release pressure waves that travel into the dermis, stimulating a healing cascade that generates new collagen and elastin with minimal recovery downtime.

---

6. Candela's FDA Recalls: Historical Database Review

Analyzing a manufacturer's recall history provides clinical buyers and safety officers with objective data regarding manufacturing quality, component durability, and software reliability. An examination of the FDA recall database shows that Candela has conducted 12 terminated recall events in our device registry slice. All were classified as Class II (moderate risk) and have been resolved:

2019 Cryogen Coolant Canister Recalls (Res. Nos: Z-0206-2020 to Z-0209-2020)

• Recall Date: September 10, 2019.
• Recall Status: Terminated.
• Affected Units: 2,900 canisters in the U.S.
• Description: HFC-134a Cryogen Coolant Canisters (980g and 1000g, singles and 15-packs) used with GentleLase, GentleYAG, GentleMax Pro, and Vbeam systems.
• Root Cause: Component defect. A manufacturing defect in the canister valve assembly could lead to cryogen leakage or a failure of the valve to seal properly when connected to the laser workstation. A leaking cryogen canister presents a risk of localized frostbite to the operator's hands or erratic DCD cooling delivery during patient treatment. Candela recalled the affected lots, replaced them with verified canister stock, and corrected the valve supplier's quality control procedures.

2013 GentleLase Pro Software Design Recall (Res. No: Z-0348-2014)

• Recall Date: November 6, 2013.
• Recall Status: Terminated.
• Affected Units: 187 workstations.
• Description: Candela Laser GentleLase Pro (Model 9914-00-9015) and GentleLase Pro LE (Model 9914-00-9040) Powered Laser Surgical Instruments.
• Root Cause: Software design error. A software bug could cause the workstation's foot switch or handpiece trigger to remain active or stick, presenting a risk of unintended laser firing when the operator released the trigger. Unintended firing presents a risk of accidental laser burns to the patient or operator. Candela resolved this by deploying a software patch (version 1.4.1 or higher) to all active workstations to ensure the laser immediately cuts power when the trigger input stops.

2007 Vbeam Aesthetica/Platinum/Perfecta Recalls (Res. Nos: Z-0508-2007 to Z-0513-2007)

• Recall Date: January 15, 2007.
• Recall Status: Terminated.
• Affected Units: 234 workstations.
• Description: Vbeam Aesthetica, Platinum, and Perfecta laser systems.
• Root Cause: Calibration/Hardware instability. A potential misalignment or component degradation in the laser's internal dye kit module could cause the system to deliver energy output that deviated from the calibrated parameters displayed on the console. Deviations in energy output present a risk of ineffective treatment (if under-delivering) or skin burns (if over-delivering). Candela technicians inspected the affected systems, replaced the unstable dye modules, and updated the system's internal calibration software.

2003 Smoothbeam Laser Recall (Res. No: Z-0291-04)

• Recall Date: November 25, 2003.
• Recall Status: Terminated.
• Affected Units: 412 workstations.
• Description: Smoothbeam 1450nm Diode Laser System.
• Root Cause: Component failure. An internal power supply component failed to meet durability specifications, leading to potential electrical short-circuiting or system shutdown during operation. Candela resolved the issue by recalling the affected units and replacing the power supply modules with upgraded components.

---

7. Adverse Events: Analysis of the FDA MAUDE Database

The FDA’s Manufacturer and User Facility Device Experience (MAUDE) database compiles medical device reports (MDRs) submitted by manufacturers, healthcare facilities, and consumers. It is a critical post-market surveillance tool for identifying safety trends, though it cannot establish clinical incidence rates due to under-reporting and a lack of denominator data (total treatment volumes).

A search of the FDA MAUDE database summary reveals 385 reports associated with Candela devices:

• Injury Reports: 245
• Malfunction Reports: 114
• Other/Unspecified Reports: 24
• Death Reports: 0 (Unlike invasive surgical energy systems, Candela's non-invasive aesthetic portfolio shows zero death reports in the registry).
• Unspecified/NaN: 2

Event Distribution by Brand

1. GentleLase Laser System: 47 reports
2. GentleMax Pro: 32 reports
3. GentleLase (unspecified model): 23 reports
4. Vbeam Perfecta: 17 reports
5. GentleMax: 17 reports
6. GentleCool (cooling accessory): 8 reports
7. GentleYAG: 7 reports

MAUDE Adverse Event Distribution
Candela (385 total reports, by manufacturer)
  ├── Injury: 245 (63.6%)
  ├── Malfunction: 114 (29.6%)
  ├── Other: 24 (6.2%)
  └── Unspecified: 2 (0.6%)

Key Clinical Safety Analysis

GentleLase and GentleMax Pro (Hair Removal)

Adverse events are dominated by localized thermal injuries and pigmentary changes:

• Thermal Burns and Blistering: These are typically technique-dependent burns. They occur when the operator uses excessive fluence, selects an incorrect skin type setting (such as using Alexandrite settings on Fitzpatrick V skin), or fails to maintain flat contact between the distance gauge and the skin.
• DCD Cryogen Malfunctions: Several reports describe burns caused by DCD failures, such as a clogged cryogen nozzle that failed to spray coolant, or a leaking valve that dripped liquid cryogen directly onto the skin, causing localized frostbite/cryo-burns.
• Post-Inflammatory Hyperpigmentation (PIH) and Hypopigmentation: These occur when thermal energy injures melanocytes. Hypopigmentation (white spots) is particularly common when treating tanned skin or using incorrect Alexandrite settings on dark skin.
• Paradoxical Hypertrichosis: An adverse event where laser treatments stimulate new, fine hair growth in adjacent untreated zones. This is most commonly reported in female patients of Mediterranean, Middle Eastern, or South Asian descent when treating fine vellus hair on the face or neck with sub-therapeutic fluences.

Vbeam Perfecta & Prima (Vascular PDL)

• Severe Purpura and Swelling: Ruptured blood vessels lead to localized bleeding under the skin. While purpura is often an intended clinical endpoint for resistant vascular lesions, patients occasionally report it as an adverse event due to inadequate pre-procedure education regarding social downtime.
• Blistering and Scarring: Burns can occur if the skin is prepped with alcohol-based sanitizers that have not fully evaporated before the laser pulse, creating a fire hazard.

---

8. Clinical Trial Milestones: Evidence for Approvals

Candela's FDA clearances are supported by clinical trials that establish safety and efficacy parameters:

PicoWay Tattoo and Pigment Clearance (K140880)

• Study Design: A multi-center prospective study evaluated the clearance of multi-colored tattoos in subjects who had previously undergone unsuccessful treatments with nanosecond Q-switched lasers.
• Efficacy Endpoints: Blinded evaluations of clinical photographs showed that over 85% of subjects achieved good-to-excellent clearance of black, blue, and green inks after 4 to 6 picosecond treatments.
• Safety Profile: Transient erythema, localized edema, and mild purpura were expected endpoints. No cases of hypertrophic scarring or permanent hypopigmentation were reported, validating the safety profile of the photomechanical mechanism.

Vbeam Prima Rosacea Evaluation (K193237)

• Study Design: Clinical trials evaluated the Vbeam Prima's dual-wavelength configuration (595nm and 1064nm) for the treatment of facial redness and telangiectasias in rosacea patients.
• Efficacy Endpoints: Patients received three treatments spaced 4 weeks apart. Quantitative redness measurements showed a significant reduction in erythema index scores, with over 90% of subjects reporting high satisfaction.
• Safety Profile: Epidermal protection was verified using both DCD and contact cooling. Mild swelling was common post-treatment, but resolved within 48–72 hours without scarring.

Profound Dermal Remodeling Clinical Data (K101185)

• Study Design: A pivotal multi-center study evaluated the temperature-controlled RF microneedling system in subjects with mild-to-moderate facial laxity.
• Efficacy Endpoints: The trial measured a clinical response rate of 100% for wrinkles and 95% for laxity at 6 months post-treatment, as graded by independent board-certified dermatologists.
• Safety Profile: Localized bruising and swelling were common, resolving within 7 to 10 days. The real-time temperature feedback loop prevented epidermal burns or dermal scarring.

---

9. Regulatory Compliance and Buying Guide for Practice Managers

For practice managers, medical directors, and laser technicians, purchasing and operating Candela platforms requires a structured compliance and maintenance framework:

Used Candela Workstation Purchase Checklist

Due to the high cost of new platforms, many clinics purchase refurbished Candela workstations. Practice managers should execute this specific quality audit prior to completing a purchase:

Maintenance and Room Safety Controls

Class IV medical lasers require strict safety controls to prevent irreversible ocular damage:

• Nominal Ocular Hazard Distance (NOHD): For Candela systems, the NOHD can exceed 100 meters. The laser room door must be closed during treatment, windows must be covered with opaque blocking shields, and warning signs must be posted at all entrances.
• Eye Protection (OD Values): Operators and patients must wear laser safety glasses matching the target wavelength. For the Alexandrite (755nm) wavelength, eyewear must have an Optical Density (OD) of 7 or higher. For the Nd:YAG (1064nm) and Pulsed Dye (595nm) wavelengths, the OD must be 6 or higher. The specific wavelengths and ODs are printed on the frames.

---

10. FAQs

Is the PicoWay laser FDA-cleared?

Yes. The Candela PicoWay laser system is FDA-cleared under product code GEX. It holds clearances for tattoo removal, benign pigmented lesions, acne scars, and wrinkles.

What is the purpose of Candela's GEX product code?

GEX is the FDA product code for "Laser instrument, surgical" regulated under 21 CFR 878.4810. It is a Class II regulatory classification. Candela holds 102 clearances under this code, covering their main Nd:YAG, alexandrite, and pulsed dye laser systems.

What is the function of the Dynamic Cooling Device (DCD)?

The DCD protects the skin during laser treatments by spraying a brief burst of cryogen coolant (HFC-134a) onto the epidermis milliseconds before and after the laser pulse. This cools the outer layer of the skin, reducing the risk of burns while allowing the laser energy to target hair follicles or blood vessels.

Are there active recalls for Candela GentleMax Pro or PicoWay in 2026?

According to the FDA database, there are no active, open recalls for the GentleMax Pro or PicoWay platforms. The historical recalls, including the 2019 cryogen canister recall and the 2013 GentleLase Pro software recall, have been terminated after corrective actions were completed.

What are the main side effects of Vbeam pulsed dye laser treatments?

Common side effects include swelling, redness, and transient purpura (bruising), which is an expected clinical endpoint when targeting resistant blood vessels. Rare complications include blistering, crusting, and post-inflammatory hyperpigmentation, typically resolving within a few weeks with proper care.

Can the Profound RF system treat dark skin safety?

Yes. Profound RF is safe for all Fitzpatrick skin types (I–VI) because it delivers radiofrequency energy directly into the dermis via insulated needles, bypassing the melanin-rich epidermis. This minimizes the risk of post-inflammatory hyperpigmentation compared to surface-heating energy devices.

How does the PicoWay picosecond pulse duration improve tattoo removal safety?

PicoWay's picosecond pulse width (10^-12 seconds) is shorter than the thermal relaxation time of tattoo ink particles. This allows the laser energy to build up pressure rapidly, shattering the ink photomechanically. This minimizes heat transfer to surrounding skin, reducing the risk of scarring and thermal burns compared to older Q-switched (nanosecond) lasers.

What was the cause of the 2013 GentleLase Pro recall?

The GentleLase Pro software design recall was initiated due to a software error that could cause the trigger or foot switch to stick. This presented a risk of unintended laser firing after the trigger was released, creating a burn hazard. The recall was resolved through software updates deployed by Candela.

How does the Vbeam Prima system differ from the Vbeam Perfecta?

The Vbeam Prima is the next-generation pulsed dye laser. It adds a 1064nm Nd:YAG wavelength to the classic 595nm PDL, increases maximum spot size to 15mm, and supports contact cooling in addition to DCD cryogen spray.

How often should Candela laser handpieces be calibrated?

Candela laser handpieces require calibration checks at the start of every clinical day or session. The system's internal energy meter verifies that the power delivered at the distal handpiece tip matches the settings programmed on the user console.

What is the clinical significance of Candela's OLP product code?

OLP is the FDA product code for "Laser Surgical Instrument, Gynecologic" regulated under 21 CFR 884.4530. Candela holds one clearance under this code, which was developed to evaluate laser applications in gynecological procedures. This code is distinct from their primary GEX surgical laser codes and represents a specialized, minor segment of the historical product line.

What are the post-treatment guidelines for PicoWay Resolve skin treatments?

Post-treatment care for Resolve fractional treatments is minimal compared to ablative lasers. Patients should apply a mild moisturizer, avoid active ingredients (like retinoids or acids) for 3–5 days, and use a broad-spectrum sunscreen daily. Transient redness usually resolves within 24 hours.

---

Sources

1. FDA 510(k) Premarket Notification Database: FDA 510(k) Search Tool (Referencing clearances K222564 for PicoWay, K193237 for Vbeam Prima, K181523 for GentleMax Pro, and ePrime/Profound K101185).
2. FDA Medical Device Recalls Database: FDA Class II Recall Database (Referencing Res. Nos. Z-0206-2020 to Z-0209-2020 for the cryogen canister recall and Z-0348-2014 for the GentleLase Pro software recall).
3. FDA Manufacturer and User Facility Device Experience (MAUDE) Database: FDA MAUDE Search Tool (Extracted and aggregated data for Candela Corporation devices).
4. Candela Corporate and Clinical Publications: Candela Medical Platforms (Prescribing information, clinical guidelines, and DCD configuration metrics).